- Home
- PASG vs PLUR Comparison
PASG vs PLUR Comparison
Compare PASG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- PLUR
- Stock Information
- Founded
- PASG 2017
- PLUR 2001
- Country
- PASG United States
- PLUR Israel
- Employees
- PASG N/A
- PLUR N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PASG Health Care
- PLUR Health Care
- Exchange
- PASG Nasdaq
- PLUR Nasdaq
- Market Cap
- PASG 31.1M
- PLUR 33.6M
- IPO Year
- PASG 2020
- PLUR N/A
- Fundamental
- Price
- PASG $0.27
- PLUR $4.85
- Analyst Decision
- PASG Strong Buy
- PLUR
- Analyst Count
- PASG 3
- PLUR 0
- Target Price
- PASG $7.67
- PLUR N/A
- AVG Volume (30 Days)
- PASG 240.1K
- PLUR 36.3K
- Earning Date
- PASG 05-13-2025
- PLUR 05-20-2025
- Dividend Yield
- PASG N/A
- PLUR N/A
- EPS Growth
- PASG N/A
- PLUR N/A
- EPS
- PASG N/A
- PLUR N/A
- Revenue
- PASG N/A
- PLUR $1,034,000.00
- Revenue This Year
- PASG N/A
- PLUR $472.39
- Revenue Next Year
- PASG N/A
- PLUR $254.29
- P/E Ratio
- PASG N/A
- PLUR N/A
- Revenue Growth
- PASG N/A
- PLUR 89.92
- 52 Week Low
- PASG $0.30
- PLUR $3.33
- 52 Week High
- PASG $1.64
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- PASG 34.53
- PLUR 49.79
- Support Level
- PASG $0.33
- PLUR $5.11
- Resistance Level
- PASG $0.42
- PLUR $6.10
- Average True Range (ATR)
- PASG 0.05
- PLUR 0.46
- MACD
- PASG -0.00
- PLUR 0.00
- Stochastic Oscillator
- PASG 5.82
- PLUR 15.97
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.